孕11–14周超声检出非心脏胎儿异常的系统评价与Meta分析
该系统评价与Meta分析纳入52项研究、527 837例胎儿,评估孕11–14周二维超声筛查16种非心脏先天畸形的诊断准确性。重度畸形检出率高(如无脑畸形98%、腹裂96%),而唇裂43%、多指40%、先天性膈疝38%、双肾缺如25%、闭合性脊柱裂21%、孤立性唇裂14%、足内翻11%检出率低,所有畸形特异度均>99%。标准化方案对筛查性能有统计学显著影响(P<0.0001),检出率随发表年份提高而改善。
要点
- 早孕期超声对无脑畸形(98%)、腹裂(96%)、脐膨出(95%)、前脑无裂畸形(88%)检出率高。
- 唇裂(43%)、多指(40%)、先天性膈疝(38%)、双肾缺如(25%)、闭合性脊柱裂(21%)、孤立性唇裂(14%)、足内翻(11%)检出率低。
- 所有16种畸形特异度均>99%,标准化成像方案对筛查性能有统计学显著影响(P<0.0001)。
核心结论
- 孕11–14周超声准确检出先天畸形是可行的,但检出率与假阳性率取决于畸形类型,采用标准化方案可使诊断性能最大化,尤其利于检出脊柱裂、唇裂和肢体缩减缺陷。
研究设计与样本
- 系统评价与Meta分析,PROSPERO注册(CRD42018111781),检索MEDLINE、EMBASE、Web of Science核心合集和Cochrane图书馆,纳入52项研究共527 837例胎儿(其中2399例受累于16种预设畸形之一),纳入前瞻性与回顾性研究,参考标准为出生后或尸检发现异常,采用随机效应模型,偏倚风险用QUADAS-2工具评估。
诊断标准与关键数值
- 16种非心脏先天畸形的检出率:无脑畸形98%、腹裂96%、脐膨出95%、前脑无裂畸形88%、开放性脊柱裂69%、下尿路梗阻66%、致死性骨骼发育不良57%、肢体缩减缺陷50%、面部裂43%、多指40%、先天性膈疝38%、双侧肾缺如25%、闭合性脊柱裂21%、孤立性唇裂14%、足内翻11%;所有畸形特异度均>99%。
临床应用与阅片要点
- 标准化成像方案对筛查性能有统计学显著影响(P<0.0001),检出率随发表年份提高而改善;作者认为明确可诊断的畸形类型和提升筛查性能的因素可支持早孕期畸形筛查方案的制定。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess the diagnostic accuracy of two-dimensional ultrasound at 11-14 weeks' gestation as a screening test for individual fetal anomalies and to identify factors impacting on screening performance.
METHODS: This was a systematic review and meta-analysis that was developed and registered with PROSPERO (CRD42018111781). MEDLINE, EMBASE, Web of Science Core Collection and the Cochrane Library were searched for studies evaluating the diagnostic accuracy of screening for 16 predefined, non-cardiac, congenital anomalies considered to be of interest to the early anomaly scan. We included prospective and retrospective studies from any healthcare setting conducted in low-risk, mixed-risk and unselected populations. The reference standard was the detection of an anomaly on postnatal or postmortem examination. Data were extracted to populate 2 × 2 tables and a random-effects model was used to determine the diagnostic accuracy of screening for the predefined anomalies (individually and as a composite). Secondary analyses were performed to determine the impact on detection rates of imaging protocol, type of ultrasound modality, publication year and index of sonographer suspicion at the time of scanning. Post-hoc secondary analysis was conducted to assess performance among studies published during or after 2010. Risk of bias assessment and quality assessment were undertaken for included studies using the Quality Assessment of Diagnostic Accuracy Studies-2 tool.
RESULTS: From 5684 citations, 202 papers underwent full-text review, resulting in the inclusion of 52 studies comprising 527 837 fetuses, of which 2399 were affected by one or more of the 16 predefined anomalies. Individual anomalies were not equally amenable to detection on first-trimester ultrasound: a high (> 80%) detection rate was reported for severe conditions, including acrania (98%), gastroschisis (96%), exomphalos (95%) and holoprosencephaly (88%); the detection rate was lower for open spina bifida (69%), lower urinary tract obstruction (66%), lethal skeletal dysplasias (57%) and limb-reduction defects (50%); and the detection rate was below 50% for facial clefts (43%), polydactyly (40%) and congenital diaphragmatic hernia (38%). Conditions with a low (< 30%) detection rate included bilateral renal agenesis (25%), closed spina bifida (21%), isolated cleft lip (14%) and talipes (11%). Specificity was > 99% for all anomalies. Secondary analysis showed that detection improved with advancing publication year, and that the use of imaging protocols had a statistically significant impact on screening performance (P < 0.0001).
CONCLUSIONS: The accurate detection of congenital anomalies using first-trimester ultrasound is feasible, although detection rates and false-positive rates depend on the type of anomaly. The use of a standardized protocol allows for diagnostic performance to be maximized, particularly for the detection of spina bifida, facial clefts and limb-reduction defects. Highlighting the types of anomalies amenable to diagnosis and determining factors enhancing screening performance can support the development of first-trimester anomaly screening programs. © 2024 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Karim JN, Di Mascio D, Roberts N, et al. Detection of non-cardiac fetal abnormalities on ultrasound at 11-14 weeks: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2024. PMID: 38547384. doi:10.1002/uog.27649
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。